On Wednesday, Tempus AI earned an upgrade to its Relative Strength (RS) Rating, from 89 to 92.
Looking For The Best Stocks To Buy And Watch? Start Here
This proprietary rating identifies technical performance by showing how a stock's price action over the last 52 weeks measures up against that of the other stocks in our database.
History shows that the best stocks tend to have an RS Rating of over 80 in the early stages of their moves.
Now is not an ideal time to jump in since it isn't near a proper buy zone, but see if the stock is able to offer and clear a proper buy point.
The company showed 0% EPS growth in its most recent report. Sales rose 75%.
Tempus AI holds the No. 1 rank among its peers in the Medical-Research Equipment/Services industry group. Fulgent Genetics and Schrodinger are also among the group's highest-rated stocks.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
